Argentina

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Argentina

Argentina

Medical guidelines

National health department

Government health insurance

Private health insurance

Access to care

Ampligen (rintatolimod) has been approved for use by the Argentine Republic for severe ME/CFS as of August 23, 2016.[1]

Social security and disability benefits

Patient charities

Research

Research groups

Researchers

Clinicians

Notable patients

Deceased patients

Learn more

See also

References